US-based biotech company Sana Biotechnology has released clinical data showing that the first person receiving engineered islets from deceased donors is now producing insulin without
The Ypsomed Innovation Award 2025 has been won by Yuon Control AG. The aim of the Innovation Award, which grants a total of CHF 100,000
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, said Medtronic’s CEO Geoff Martha at the recent J.P. Morgan
The University of Liverpool’s AI diagnostic technology spin-out, AI-Sight, has successfully concluded its seven-figure equity funding round from experienced healthcare industry figures and investors. The
Sheffield Teaching Hospitals NHS Foundation Trust has launched a trial utilising smart technologies with the aim of reversing the risk of nerve damage in people
A collection of guidance has been published by the Medicines and Healthcare products Regulatory Agency (MHRA) to update manufacturers of medical devices on new regulations.
Beta Bionics, developer of an automated insulin delivery system, has recently filed for an initial public offering. The company has not disclosed the number of
Dexcom’s CEO Kevin Sayer has shared new data on the company’s first over-the-counter glucose sensor at the recent J.P. Morgan Healthcare Conference in America earlier
The US Food and Drug Administration (FDA) has cleared the Abbott Libre 2 and 3 continuous glucose monitoring (CGM) sensors for use during most imaging
Medtronic has announced plans to submit its MiniMed 780G for an expanded indication from the FDA for Type 2 diabetes in the first half of